
Cytomics Limited is a development stage startup based in Hong Kong. They offer proprietary computational biology solutions that provide new types of single cell type biomarkers for disease diagnosis and prognosis. Their focus is on developing single cell-type biomarker tests for clinical use, utilizing a novel analytical algorithm that leverages advances in single cell sequencing (scRNA-seq) and machine learning. The company aims to create a simple blood test that provides information about the status of a single cell type. Cytomics Limited is actively seeking investors and partners to further develop their research-use diagnostics products.

Cytomics Limited is a development stage startup based in Hong Kong. They offer proprietary computational biology solutions that provide new types of single cell type biomarkers for disease diagnosis and prognosis. Their focus is on developing single cell-type biomarker tests for clinical use, utilizing a novel analytical algorithm that leverages advances in single cell sequencing (scRNA-seq) and machine learning. The company aims to create a simple blood test that provides information about the status of a single cell type. Cytomics Limited is actively seeking investors and partners to further develop their research-use diagnostics products.